Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Robert Bensen"'
Autor:
Matthew Wong-Pack, Aashish Kalani, Jacob Hordyk, George Ioannidis, Robert Bensen, William G. Bensen, Alexandra Papaioannou, Jonathan D. Adachi, Arthur N. Lau
Publikováno v:
Journal of Osteoporosis, Vol 2016 (2016)
Although denosumab (Prolia) has been shown to be a safe and efficacious therapy for osteoporotic patients in numerous clinical trials, few studies have determined its effectiveness in real world clinical practice. A retrospective review of patients p
Externí odkaz:
https://doaj.org/article/f7124234f05d49c8a7f1859c25d58e68
Autor:
Louise H. Comas, Cameron Hunter, Lauren Nalezny, Sean M. Gleason, Robert Bensen, Satya Chintamanani
Publikováno v:
Physiologia plantarumREFERENCES. 172(4)
There is increasing interest in understanding how trait networks can be manipulated to improve the performance of crop species. Working towards this goal, we have identified key traits linking the acquisition of water, the transport of water to the s
Autor:
Cameron Hunter, Satya Chintamanani, Lauren Nalezny, Louise H. Comas, Sean M. Gleason, Robert Bensen
There is increasing interest in understanding how trait networks can be manipulated to improve the performance of crop species. Working towards this goal, we have identified key traits linking the acquisition of water, the transport of water to the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a61529c209f7e5fc5f44ae28a544ed50
https://doi.org/10.1101/2021.02.04.429760
https://doi.org/10.1101/2021.02.04.429760
Autor:
George Ioannidis, Akhila Balasubramanian, Robert Bensen, Celia J. F. Lin, Rod Rodjanapiches, William G. Bensen, Arthur N. Lau, Matthew Wong-Pack, Jonathan D. Adachi, Nicola Pannacciulli, Patrick Roy-Gayos, Sally W. Wade, Leslie Spangler
Publikováno v:
The Journal of rheumatology. 45(2)
Objective.Previous studies combining biologic disease-modifying antirheumatic drugs (bDMARD) to treat rheumatoid arthritis (RA) have shown an increased risk of infection. However, the risk of infection with concurrent use of denosumab, a biologic age
Autor:
George Ioannidis, William G. Bensen, Jonathan D. Adachi, Matthew Wong-Pack, Robert Bensen, Jacob Hordyk, Alexandra Papaioannou, Aashish Kalani, Arthur N. Lau
Publikováno v:
Journal of Osteoporosis, Vol 2016 (2016)
Journal of Osteoporosis
Journal of Osteoporosis
Although denosumab (Prolia) has been shown to be a safe and efficacious therapy for osteoporotic patients in numerous clinical trials, few studies have determined its effectiveness in real world clinical practice. A retrospective review of patients p
Autor:
Mary E. Stuckey, Denise Low, John Richard Beery, Susan Lobo, Margaret B. Blackman, Darby Li Po Price, Joanna C. Scherer, Robert Bensen, Rolland Dewing, Dean Rader, James Taylor Carson, Scott J. Howard, David Arnold, Charlotte J. Frisbie, Derek Milne, Michael Leroy Oberg, Ronald K. Inouye, Erik Trump, Catherine R. Davids
Publikováno v:
American Indian Culture and Research Journal. 23:149-207
Autor:
Hao, Wu, Colin, Webber, Carmen Otero, Fuentes, Robert, Bensen, Karen, Beattie, Jonathan D, Adachi, Xiaoming, Xie, Farhang, Jabbari, David R, Levy
Publikováno v:
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 58(3)
1) To assess, with a peripheral magnetic resonance imaging system (pMRI), the prevalence of bony and soft tissue abnormalities in the knee joints of normal subjects, osteoarthritis (OA) patients, and individuals who have suffered an anterior cruciate
Autor:
Alexandra Papaioannou, Jonathan D. Adachi, William G. Bensen, Timothy M. Murray, Wojciech P. Olszynski, David A. Hanley, George Ioannidis, Rolf J. Sebaldt, Mark Puglia, Robert G. Josse, Jacques P. Brown, Charles H. Goldsmith, Annie Petrie, Robert Bensen
Publikováno v:
BMC Musculoskeletal Disorders, Vol 6, Iss 1, p 47 (2005)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders
Background Fracture represents the single most important clinical event in patients with osteoporosis, yet remains under-predicted. As few premonitory symptoms for fracture exist, it is of critical importance that physicians effectively and efficient
Publikováno v:
Annals of the Rheumatic Diseases. 73:876.3-877
Background Biological drugs have dramatically improved the prognosis of rheumatoid arthritis (RA), especially in those with early disease. These patientsare often in younger age with fewer co-morbidities. Recent Canadian data suggests the highest inc